120757-13-3 Usage
General Description
4-(4-aminophenyl)-3-methyl-4-oxobutanoic acid hydrochloride is a chemical compound with the molecular formula C11H13NO3·HCl. It is an important intermediate in the production of pharmaceuticals and is commonly used in the synthesis of various drugs and active pharmaceutical ingredients. 4-(4-aMinophenyl)-3-Methyl-4-oxobutanoic acid hydrochloride has a wide range of applications in the pharmaceutical industry, as it can be used in the synthesis of analgesics, anti-inflammatory drugs, and other therapeutic agents. It is also used as a reagent in organic synthesis and drug discovery research. Additionally, it is a potent inhibitor of serine proteases, making it a valuable tool in biochemical and pharmacological research.
Check Digit Verification of cas no
The CAS Registry Mumber 120757-13-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,7,5 and 7 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 120757-13:
(8*1)+(7*2)+(6*0)+(5*7)+(4*5)+(3*7)+(2*1)+(1*3)=103
103 % 10 = 3
So 120757-13-3 is a valid CAS Registry Number.
120757-13-3Relevant articles and documents
DIHYDROPYRIDAZINONES SUBSTITUTED WITH PHENYLUREAS
-
Page/Page column 201, (2018/05/27)
Compounds of formula (I) which are nicotinamide phosphoribosyltransferase (NAMPT) inhibitors and their use for the treatment of hyperproloferative diseases and/or disorders responsive to induction of cell death.
Studies on agents with vasodilator and β-blocking activities. IV
Seki, Toshimi,Nakao, Tomio,Masuda, Takeshi,Hasumi, Kohichi,Gotanda, Kotaro,Ishimori, Tsutomu,Honma, Seijiro,Minami, Nobuyoshi,Shibata, Kenyu,Yasuda, Kikuo
, p. 2061 - 2069 (2007/10/03)
A series of novel pyridazinone derivatives (II) having a phenoxypropanolamine moiety was synthesized. Their hypotensive and β- blocking activities were evaluated after intravenous administration of the compounds to anesthetized rats. Among them, the 5-chloro-2-cyanophenoxy derivative (29) showed the promising dual activities and was selected for further studies.